{"id":"W2970398865","doi":"10.1038/s41375-019-0554-1","title":"Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital de l'Enfant-Jésus","funders":"F. Hoffmann-La Roche; Roche","keywords":"Fludarabine; Medicine; Obinutuzumab; Cyclophosphamide; Internal medicine; Chronic lymphocytic leukemia; Neutropenia; Tolerability; Gastroenterology; Clinical endpoint; Surgery; Oncology; Adverse effect; Leukemia; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002234338,0.0008854049,0.002220868,0.0006694656,0.0003134455,0.0008461056,0.0004172491,0.0007501571,0.001146239],"category_scores_gemma":[0.001501625,0.0002839175,0.004029455,0.0007399106,0.0003485439,0.0004618794,0.0004951414,0.0007589488,0.000144281],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005769691,"about_ca_system_score_gemma":0.0006868869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001134962,"about_ca_topic_score_gemma":0.003753118,"domain_scores_codex":[0.9990168,0.0004757259,0.0001177619,0.0001564845,0.00009177297,0.0001413882],"domain_scores_gemma":[0.9992937,0.0002091488,0.0001798584,0.0001181294,0.00005164139,0.0001473768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.748063,0.002130298,0.1671311,0.001154314,0.02748825,0.0007907918,0.0002905032,0.001323338,0.01409671,0.0001851516,0.001907486,0.0354391],"study_design_scores_gemma":[0.2739405,0.1024913,0.5544007,0.0003389783,0.04671855,0.001813232,0.0009527785,0.004565375,0.003870171,0.001098185,0.009653362,0.0001568041],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942667,0.004230855,0.0001500015,0.0001040223,0.00004040233,0.000260529,0.0006107943,0.000009087079,0.0003275826],"genre_scores_gemma":[0.9968309,0.0006789498,0.0002156753,0.0002454565,0.00008092344,0.0002381382,0.001465341,0.000007947718,0.0002367471],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002234338,"threshold_uncertainty_score":0.01181644,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008137454278293835,"score_gpt":0.2441764220748079,"score_spread":0.2360389677965141,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}